The Cocktail Report (sound really smart around your friends):
Mice had their growth hormone receptor switched off at 12 months, roughly age 40 in human terms.
Median lifespan rose 8% in females, from 929 to 1,003 days, and the longest-lived female gained 12%.
Males lived longer overall, but their 7% gain in median lifespan fell just short of statistical significance.
Treated males gained fat yet handled blood sugar better and kept more grip strength and balance.
There was no drop in cancer deaths and no change in a standard frailty score.
If you have seen growth hormone injections marketed as a way to feel younger, a study published this month in Aging Cell points the other way. In mice, less growth hormone activity starting in midlife meant a longer life.
The question behind it is one that matters for any anti-aging treatment you might someday take: does it still work if you start in middle age, rather than at birth?
Why start in midlife
Growth hormone, made by the pituitary gland at the base of the brain, drives childhood growth. It also tells the liver to make IGF-1, insulin-like growth factor 1, a hormone that promotes cell growth and makes the body less responsive to insulin.
Mice born without a working growth hormone receptor hold the record as the longest-lived laboratory mice. People with Laron syndrome, a rare inherited condition in which that receptor does not work, show striking resistance to cancer and diabetes.
But a lifelong deficit also stunts growth. Any treatment for adults would have to begin after growth is done, so the Ohio University team tested what happens when the receptor is removed in 12-month-old mice.
The experiment
The researchers used mice engineered so that a drug, tamoxifen, would delete the growth hormone receptor gene throughout the body. At 12 months, one group got tamoxifen and the controls got a harmless oil injection.
A lifespan group of 30 to 35 mice per sex and treatment was followed until natural death. Two smaller groups of 9 to 12 mice each were examined at 19 and 23 months.
The deletion worked. IGF-1 in the blood fell sharply, and growth hormone rose as the body tried to compensate.
Lifespan results
Survival curves were significantly better in both sexes. In females, median lifespan rose from 929 to 1,003 days, about 8%, and the longest-lived treated female reached 1,231 days versus 1,097 for controls.
In males, median lifespan went from 943 to 1,011 days, about 7%, but that gap missed statistical significance (P = 0.064). Maximum lifespan in males did not change.
The authors note that lifelong models extend lifespan by 20% to 60%. Starting in midlife bought far less.
Health results, mostly in males
Treated mice of both sexes carried more body fat and less lean muscle. That sounds bad, yet treated males handled blood sugar better and responded more strongly to insulin.
Males also held on to more grip strength and balance for their muscle mass, and kept denser spinal bone. Females showed no measurable change in strength or balance.
The fine print
A standard mouse frailty score, which adds up small health deficits, did not differ between groups in either sex. Fatal tumors turned up just as often as in the controls.
The treated mice lived longer but died of the same diseases, just later. The team also found that the male liver shifted toward a more female pattern of gene activity, a change whose long-term meaning is unknown.
What this means for you
Nobody should try to block their own growth hormone, and no approved drug does this for aging. This is one mouse strain, with a genetic deletion that no pill can yet reproduce.
The more useful takeaway concerns what you might buy today. If a clinic offers growth hormone to slow aging, this study adds to a long line of animal evidence suggesting that more growth hormone activity in adulthood runs in the wrong direction for lifespan.
Why Should You Care?
Growth hormone is sold as a youth hormone, yet mice lived longer when its signal was cut off in midlife. Before paying for any hormone marketed to slow aging, ask what the lifespan evidence says, not just how it makes you feel.
1. Duran-Ortiz S, List EO, Young JA, et al. Midlife growth hormone receptor ablation extends healthy lifespan and induces sex-specific hepatic transcriptional changes at single-cell resolution. Aging Cell. 2026 Sep. doi:10.1111/acel.70695. PMID 42698366. https://pmc.ncbi.nlm.nih.gov/articles/PMC13545643/
